The frequency of bone/muscle pain can be reduced by giving G-CSF either two days before or two days after IFN injection.71 Rarely, splenomegaly and spontaneous splenic rupture have also been reported with G-CSF use.72–73 Marked granulocytosis may occur with prolonged therapy. The gene discussed is IFNA1; the disease is Splenomegaly.